低剂量纳尔特雷克松用于管理COVID-19后急性后果
Hector Bonilla1, Lu Tian2, Vincent C Marconi3
1Division of Infectious Diseases & Geographic Medicine, L-134 Stanford University, 300 Pasteur Dr., Palo Alto, CA 94305, United States.
International immunopharmacology
|October 7, 2023
概括
低剂量纳尔特雷 (LDN) 可能缓解长期的COVID症状. 一项回顾性研究发现,LDN使用与SARS-CoV-2感染 (PASC) 的急性后续患者的症状减少和功能改善有关.
科学领域:
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- SARS-CoV-2 感染 (PASC) 后急性后续,或长期COVID,影响了COVID-19幸存者的很大一部分.
- PASC的确切原因尚不清楚,但持续的炎症和免疫细胞激活是主要假设.
- 目前用于PASC的治疗方法缺乏FDA的批准.
研究的目的:
- 为了研究低剂量纳尔特雷 (LDN) 对PASC患者的潜在治疗效果.
- 评估LDN对PASC队列中症状负担和功能状态的影响.
主要方法:
- 对59名被诊断患有PASC的患者的临床队列进行了回顾性审查.
- 患者接受非标签低剂量纳尔特雷克森 (LDN) 作为潜在的干预措施.
- 分析症状减轻,临床症状改善和功能状态变化.
主要成果:
- 使用LDN与报告的PASC症状数量的减少有关.
- 在关键症状中观察到显著的改善,包括疲劳,运动后的不适,不清爽的睡眠和异常的睡眠模式.
- 接受LDN治疗的患者表现出功能状态的改善.
结论:
- 低剂量纳尔特雷克松 (LDN) 显示出作为SARS-CoV-2感染 (PASC) 后急性后续症的潜在治疗方法的希望.
- 在减轻症状和改善功能方面观察到的好处需要进一步研究.
- 建议进行严格的随机,安慰剂控制的临床试验,以证实这些发现.
相关概念视频
Nephrotic Syndrome II : Assessment and Medical Management
8
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
8
CNS Depressants: Alcohol and Nicotine
226
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
226
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
292
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
292
Analgesia and Pain Management
640
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
640
Opioid Analgesics: Synthetic and Semisynthetic Opioids
318
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
318
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
141
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
141


